⬡ THIRD-PARTY HPLC TESTED⬡ >98% PURITY GUARANTEED⬡ CERTIFICATE OF ANALYSIS INCLUDED⬡ PREMIUM GRADE COMPOUNDS⬡ FAST TRACKED SHIPPING⬡ 24 PREMIUM PEPTIDES⬡ THIRD-PARTY HPLC TESTED⬡ >98% PURITY GUARANTEED⬡ CERTIFICATE OF ANALYSIS INCLUDED⬡ PREMIUM GRADE COMPOUNDS⬡ FAST TRACKED SHIPPING⬡ 24 PREMIUM PEPTIDES⬡ THIRD-PARTY HPLC TESTED⬡ >98% PURITY GUARANTEED⬡ CERTIFICATE OF ANALYSIS INCLUDED⬡ PREMIUM GRADE COMPOUNDS⬡ FAST TRACKED SHIPPING⬡ 24 PREMIUM PEPTIDES⬡ THIRD-PARTY HPLC TESTED⬡ >98% PURITY GUARANTEED⬡ CERTIFICATE OF ANALYSIS INCLUDED⬡ PREMIUM GRADE COMPOUNDS⬡ FAST TRACKED SHIPPING⬡ 24 PREMIUM PEPTIDES
Looksmaxxing Protocol

The 12-Week
Looksmaxxing Peptide Stack

A phased, mechanistically-sound protocol for aesthetic optimization. Three tiers of intensity — from beginner topical-only to advanced full stack — each with clear entry criteria, dosing tables, and expected results by week.

For laboratory and research use only. Not for human consumption.
3
Protocol phases
skin → GH axis → advanced
12 wk
Standard full cycle length
+ 4-week off period
5
Compounds in full stack
from topical to injectable
4–8×
GH pulse amplification
from CJC-1295 + Ipamorelin
Week 8
Visible results onset
for intermediate stack
Choose Your Level

Three Protocol Tiers

Select the tier that matches your experience level and goals. Do not jump to Advanced without completing prior cycles — the phased structure exists for a reason.

Beginner
Phase 1 Only

No injectable peptides. No GH axis compounds. Topical-only protocol for skin collagen and expression line reduction. Ideal for anyone new to peptide research or under 25.

Compounds
  • GHK-Cu (topical)
  • SNAP-8 (topical)
Risk Level
Very Low
Improved skin texture
Intermediate
Phase 1 + 2

Adds sleep-timed GH secretagogue stack to the skin foundation. GH axis optimization drives lean tissue preservation, reduced facial bloat, and indirect bone density support. Suitable after completing one skin-only cycle.

Compounds
  • GHK-Cu (topical or injectable)
  • SNAP-8 (topical)
  • CJC-1295 (no DAC) + Ipamorelin
Risk Level
Low–Moderate
All beginner changes plus: leaner facial contour
Advanced
Full Stack

Adds IGF-1 LR3 for direct satellite cell activation (masseter/muscle density) and optionally Retatrutide for submental fat clearance. For experienced researchers only — requires prior bloodwork and cycle history.

Compounds
  • GHK-Cu
  • SNAP-8
  • CJC-1295 (no DAC) + Ipamorelin
  • IGF-1 LR3 (add one compound at a time)
  • Retatrutide (if fat loss is goal)
Risk Level
Moderate
All intermediate changes plus: measurable muscle density improvements
Phase Breakdown

Week-by-Week Protocol

Each phase builds on the previous. Never introduce Phase 3 compounds before completing Phase 2. The sequenced approach allows you to isolate variables and understand what each compound contributes.

Phase 1

Weeks 1–4 — Skin Foundation

Goal: Establish collagen synthesis and SNARE inhibition baseline before introducing injectable compounds.

GHK-Cu

View
Dose
Topical: apply twice daily to face/neck. Injectable: 500mcg–1mg subQ, 3–5×/week
Timing
Morning + evening topical, or morning injectable
Mechanism
Initiates collagen I/III gene upregulation, SOD antioxidant activation, TIMP-1/2 elevation to reduce collagen breakdown

SNAP-8

View
Dose
Topical: apply twice daily to expression line target areas (forehead, crow's feet, glabellar)
Timing
Morning + evening — apply 10–15 min after GHK-Cu absorption
Mechanism
Competitive SNAP-25 inhibition reduces acetylcholine vesicle fusion at neuromuscular junction — reduces muscular micro-tension that creates expression lines
What to Expect: By week 4: improved skin hydration and texture, early SNAP-8 expression line softening, GHK-Cu collagen cycle established. No dramatic visible changes yet — biological foundations are being laid.
Phase 2

Weeks 5–12 — GH Axis Activation

Goal: Sleep-timed GH pulse amplification for lean tissue optimization, bone density support, and systemic anti-aging effects.

CJC-1295 (no DAC) + Ipamorelin

View
Dose
CJC-1295: 100mcg + Ipamorelin: 100–200mcg, combined in same injection
Timing
30–60 minutes before sleep, 5 days on / 2 days off (no weekends)
Mechanism
CJC-1295 (GHRH analog) extends GH pulse duration. Ipamorelin (GHRP, GHS-R1a agonist) amplifies GH pulse amplitude. Combined: 4–8× native GH pulse during deep sleep. Downstream IGF-1 elevation drives lean tissue, bone modeling, lipolysis.

GHK-Cu (continue)

View
Dose
Continue same protocol from Phase 1
Timing
Same as Phase 1 — morning + evening topical or injectable
Mechanism
Ongoing collagen remodeling, skin thickening, and antioxidant defense. GH axis activation from Phase 2 compounds synergistically amplifies skin repair during sleep.

SNAP-8 (continue)

View
Dose
Continue same protocol from Phase 1
Timing
Same as Phase 1 — twice daily to expression areas
Mechanism
Continued SNARE inhibition. By weeks 6–8, established inhibition cycle produces visible softening of dynamic expression lines.
What to Expect: By week 8: clearly visible expression line softening (SNAP-8), collagen-driven skin firmness (GHK-Cu), early lean tissue improvements and facial fat reduction from GH axis activation. By week 12: peak Phase 2 results — sharper facial contour, measurably improved skin texture, reduced facial puffiness.
Phase 3

Weeks 9–16 (Advanced, Optional) — Advanced Layer

Goal: Direct satellite cell activation for muscle density, or accelerated fat reduction for structural definition. Add ONE compound at a time.

IGF-1 LR3 (intermediate/advanced only)

View
Dose
20–40mcg subQ, post-workout, 5 days on / 2 off
Timing
Post-workout (within 30 min) for optimal satellite cell signaling in worked muscle groups
Mechanism
Long-Arg3 modification extends IGF-1 half-life to 20–30 hours. Activates IGF-1R on skeletal muscle satellite cells — drives myofiber hyperplasia (new fiber formation) beyond what GH secretagogues achieve alone. 3× potency of native IGF-1.

Retatrutide (GLP-3R, if fat loss is goal)

View
Dose
Begin at 0.5mg/week SQ, titrate per clinical protocol
Timing
Once weekly subcutaneous injection — consistent day/time each week
Mechanism
Triple GIP/GLP-1/glucagon agonism. GLP-1: appetite suppression, gastric emptying delay. GIP: fat metabolism, insulin sensitivity. Glucagon: hepatic fat oxidation, thermogenesis. Phase 2 trial: 24.2% avg body weight reduction at 48 weeks.
What to Expect: IGF-1 LR3 (4–6 week mini-cycle): measurable muscle density improvements in worked muscle groups, including masseter hypertrophy with jaw loading. Retatrutide: significant fat loss including submental deposits by weeks 8–12 of dosing. Dramatic improvement in jaw definition from fat clearance.
Quick Reference

Complete Dosing Table

All compounds, doses, timing, and cycle structure in a single reference table.

CompoundAdminDoseTimingPhaseCycle
GHK-CuTopical / SubQTopical 2×/day or 500mcg–1mg subQMorning + evening1–312 wk on / 4 wk off
SNAP-8TopicalApply to expression areas 2×/dayMorning + evening (after GHK-Cu)1–3Ongoing
CJC-1295 (no DAC)SubQ injection100mcgPre-sleep, 5 on / 2 off2–312 wk on / 4 wk off
IpamorelinSubQ injection100–200mcg (with CJC-1295)Pre-sleep, same injection2–312 wk on / 4 wk off
IGF-1 LR3SubQ injection20–40mcgPost-workout3 only4–6 wk on / 4–6 wk off
RetatrutideSubQ injectionStart 0.5mg/wk, titrateOnce weekly3 onlyClinical GLP protocol
Expected Results

What to Expect and When

Realistic, mechanism-grounded expectations based on published compound data. Results vary significantly by individual baseline, dosing compliance, and lifestyle factors.

Week 2–4
  • Improved skin hydration and surface texture
  • Subtle expression line softening beginning
  • GHK-Cu antioxidant cascade established
GHK-CuSNAP-8
Week 5–6
  • CJC-1295/Ipamorelin added — GH pulse amplification begins nightly
  • GHK-Cu collagen synthesis measurably increasing
  • Skin tone and pore refinement visible
GHK-CuSNAP-8CJC-1295/Ipamorelin
Week 8
  • Clear expression line softening (SNAP-8 peak early effect)
  • Facial fat beginning to reduce (GH axis)
  • Skin firmness and elasticity markedly improved
  • Reduced facial puffiness, sharper contour
GHK-CuSNAP-8CJC-1295/Ipamorelin
Week 10–12
  • Peak Phase 2 results — collagen density at highest point
  • Lean facial contour clearly visible
  • Expression lines significantly softened at rest and in motion
  • Jawline and cheekbone definition improved through fat reduction
All Phase 2 compounds
Week 12+ (Advanced)
  • IGF-1 LR3 satellite cell activation — masseter density improving
  • Retatrutide submental fat clearance — jaw border sharpening
  • Full structural + skin + fat optimization in effect
All Phase 3 compounds
Protocol Rules

What NOT to Do

Do not start all compounds simultaneously
You cannot isolate what is working or what is causing any adverse response. Phase introduction is critical for clean data and safety.
Do not use IGF-1 LR3 without prior cycle history
IGF-1 LR3 is potent and not appropriate for beginners. Complete at least one full CJC-1295/Ipamorelin cycle first. Baseline bloodwork (IGF-1 serum levels) strongly recommended.
Do not stack multiple GLP-1 agonists
Combining semaglutide + tirzepatide + retatrutide creates redundant receptor agonism with amplified side effects and no additional benefit. Choose one.
Do not skip the off-period
GH axis compounds require a minimum 4-week off-period to allow receptor sensitivity to normalize. Running longer without a break diminishes returns and risks desensitization.
Do not apply SNAP-8 and GHK-Cu simultaneously
Apply GHK-Cu first, allow 10–15 minutes for absorption, then apply SNAP-8. Layer sequencing matters for topical penetration depth.
FAQ

Common Questions

What is the best peptide stack for looksmaxxing?

The most complete looksmaxxing stack addresses all four aesthetic levers: GHK-Cu for skin collagen, SNAP-8 for expression lines, CJC-1295/Ipamorelin for GH axis optimization, and optionally Retatrutide for fat loss or IGF-1 LR3 for muscle density. Use a phased approach — start with topical compounds (Phase 1), add GH secretagogues after week 4 (Phase 2), and only introduce advanced compounds after a complete prior cycle.

How long should a looksmaxxing peptide cycle be?

Standard: 12 weeks for GH axis compounds (CJC-1295/Ipamorelin), with a 4-week off-period minimum. GHK-Cu runs 12 weeks on / 4 off, or can be used topically more continuously. SNAP-8 requires ongoing daily application. Most users run two 12-week cycles per year with 4-week breaks between.

Can beginners run a full looksmaxxing peptide stack?

Start with Phase 1 only: topical GHK-Cu + SNAP-8. No injectables, no GH axis compounds. Complete one full 12-week skin cycle first. Then add CJC-1295/Ipamorelin as the second layer. Advanced compounds like IGF-1 LR3 require prior cycle history and baseline bloodwork.

Start the Protocol

Build Your Looksmaxxing Stack

All compounds HPLC-tested with CoA documentation. Start with Phase 1 topicals, or go straight to the full intermediate stack.